Sep 6, 2017· Comment from Association for Accessible Medicines (AAM)· FDA-2017-D-2232-0017
Comments from The Association for Accessible Medicines (AAM) regarding Docket FDA-2017-D-2232: Product Identifier Requirements Under the Drug Supply Chain Security Act-Compliance Policy.